Related Experiment Video
Updated: May 6, 2026

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
Exercise-induced bronchoconstriction in Tunisian elite athletes is underdiagnosed
Ridha Sallaoui1, Ines Zendah, Habib Ghedira
1Issep Sfax, Unité de Recherche "Les déterminants psychoculturels et biologiques de l'accès à la haute performance sportive," Sfax ; Department of Lung Function Testing, Abderrahmen Mami Pneumo-Allergology Hospital, Department III, Tunis, Tunisia ; Laboratoire de Physiologie de la Nutrition, Faculté des Sciences de Tunis, El Manar 1060 Tunis, Tunisia.
Abstract:
Many studies have shown an increased risk of developing exercise-induced bronchoconstriction among the athletic population, particularly at the elite level. Subjective methods for assessing exercise-induced bronchoconstriction such as surveys and questionnaires have been used but have resulted in an underestimation of the prevalence of airway dysfunction when compared with objective measurements. The aim of the present study was to compare the prevalence of exercise-induced bronchoconstriction among Tunisian elite athletes obtained using an objective method with that using a subjective method, and to discuss the possible causes and implications of the observed discrepancy. As the objective method we used spirometry before and after exercise and for the subjective approach we used a medical history questionnaire. All of the recruited 107 elite athletes responded to the questionnaire about respiratory symptoms and medical history and underwent a resting spirometry testing before and after exercise. Post-exercise spirometry revealed the presence of exercise-induced bronchoconstriction in 14 (13%) of the elite athletes, while only 1.8% reported having previously been diagnosed with asthma. In conclusion, our findings indicate that medical history-based diagnoses of exercise-induced bronchoconstriction lead to underestimations of true sufferers.
More Related Videos
Related Concept Videos
Asthma-I: Introduction
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Asthma III: Clinical Manifestations
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Asthma I: Introduction

